Found 1858 results for "cancer"
Cancer is no longer a disease of wealthy nations or aging populations alone — it is accelerating globally, and the trajectory now quantified by the World…
Why some thyroid cancers behave more indolently than others is a clinically pressing question — and the answer may lie in the immune environment shaped by a…
The shift to immediate digital release of medical test results was intended to empower patients — but empowerment requires comprehension. A nationally…
The economic burden of smoking extends far beyond healthcare spending — it quietly drains worker productivity and national social security systems in ways…
Colorectal cancer remains one of the leading causes of cancer mortality worldwide, and resistance to conventional chemotherapy and immunotherapy continues to…
Glioblastoma remains one of medicine's most stubborn failures — median survival after diagnosis hovers near 15 months despite decades of research. A central…
Understanding how tumors evade treatment has long required expensive, specialized molecular tests unavailable to most patients worldwide. A new AI platform…
The window between conception and a child's second birthday may carry far more metabolic consequence than previously appreciated. New causal evidence from a…
Excess body weight after a breast cancer diagnosis is not merely a cosmetic concern — it measurably worsens recurrence risk, treatment side effects, and…
Understanding how circadian biology varies across underrepresented populations matters more than it might appear. Most chronotype research has been conducted…
For decades, pathologists have scrutinized tumor tissue under microscopes, relying on trained intuition to spot patterns that correlate with patient outcomes…
Nutrition remains one of the most underutilized levers in cancer treatment, yet its influence on treatment tolerance, immune function, and survival outcomes…
Ovarian clear cell carcinoma has long frustrated oncologists: it resists most systemic therapies, and immune checkpoint inhibitors — transformative in…
For the roughly 40% of adults with obesity who face elevated lung cancer risk, a growing body of evidence suggests the immune system — not just metabolism…
Precision oncology for lung cancer depends entirely on knowing a tumor's molecular fingerprint — yet large portions of patients never receive that…
Gastric cancer kills roughly one million people annually worldwide, yet in the United States it is rarely screened for systematically — partly because the…
For the roughly 30% of non-small-cell lung cancer patients whose tumors have squamous histology — a subtype historically resistant to immunotherapy alone…
For the roughly 30% of non-small-cell lung cancer cases classified as squamous histology — a subtype historically less responsive to targeted therapies…
A counterintuitive intersection between oncology and cardiovascular biology is emerging: the metabolic environment created by colorectal tumors may…
The longstanding assumption that surviving an infection depends almost entirely on killing pathogens faster than they kill you is being quietly dismantled. A…